Isotretinoin REMS Still Needed, But Its Burden Could Be Reduced, FDA Staff Says
A risk evaluation and mitigation strategy (REMS) for the use of isotretinoin to treat severe acne is still very much needed, but there are ways to lighten its burden on patients and providers, according to FDA staff. For example, because of the drug’s risk of causing birth defects if taken while patients are pregnant, prescribing […]